Omega Diagnostics Gr
ODX
Delayed London Stock Exchange - 11/23 05:30:00 pm
19.5GBp
0%

Omega Diagnostics : Result of Open Offer

Envoyer par e-mail
07/17/2017 | 05:17 pm
THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF EU REGULATION 596/2014 17 July 2017 Omega Diagnostics Group plc Result of Open Offer

On 30 June 2017, Omega announced details of a Placing, Subscription and Open Offer to raise gross proceeds of approximately £3.6 million through the issue of up to 20,007,003 New Ordinary Shares at a price of 18 pence per share, with 13,116,881 shares subject to the Placing, 1,166,666 shares subject to the Subscription and up to a further 5,723,456 shares to be issued through the Open Offer.

The Open Offer closed for acceptances at 11.00 a.m. on 17 July 2017. Omega is pleased to announce that it has received valid applications under the Open Offer, including those received under the Excess Application Facility, in respect of 3,854,844 Open Offer Shares from Qualifying Shareholders. This represents approximately 67.4 per cent. of the Open Offer Shares. Qualifying Shareholders who have validly applied for Open Offer Shares and Excess Shares will receive their application in full.

The Placing, Subscription and Open Offer remain conditional, inter alia, upon the Resolutions being passed at the General Meeting to be held at 10.00 a.m. on 18 July 2017 and Admission. Omega expects to announce the results of the General Meeting as soon as practicable on 18 July 2017 after the meeting concludes. It is expected that Admission will become effective on 19 July 2017.

Capitalised terms not otherwise defined in the text of this announcement have the meanings given to them in the Company's circular dated 30 June 2017.

Contacts:

Omega Diagnostics Group PLC

Tel: 01259 763 030

Andrew Shepherd, Chief Executive

www.omegadiagnostics.com

Kieron Harbinson, Group Finance Director

Jag Grewal, Group Sales and Marketing Director

finnCap Ltd

Tel: 020 7220 0500

Geoff Nash/James Thompson (Corporate Finance)

Mia Gardner (Corporate Broking)

Walbrook PR Limited

Tel: 020 7933 8780 or [email protected]

Paul McManus

Mob: 07980 541 893

Lianne Cawthorne

Mob: 07584 391 303

1

Omega Diagnostics Group plc published this content on 17 July 2017 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 17 July 2017 15:17:07 UTC.

Envoyer par e-mail